MEI PHARMA, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.2 EUR | -17.32% |
|
-.--% | -.--% |
Chart calendar MEI Pharma, Inc.
7d7450fdb6.qUx3R-fG1S2DK1Coqi_2lFa7dweX1kBw8CXYBlFtsQo.4QEPdNaxuEzPZTnczkel1waIOWTI4SQ8xE-uZxI3xXz2NUZzioCBacpgGQ~84af5a06d540fd9ab08b012ed6441535
Upcoming events on MEI Pharma, Inc.
Past events on MEI Pharma, Inc.
| 09/05/2024 21:02 | Q3 2024 Earnings Release |
| 16/04/2024 18:30 | Stifel Virtual Targeted Oncology Days Conference |
| 13/02/2024 22:05 | Q2 2024 Earnings Release |
| 20/01/2024 14:30 | ASCO Gastrointestinal Cancers Symposium - Abstract No - TPS222 |
| 18/12/2023 17:00 | Annual General Meeting |
| 12/12/2023 02:00 | American Society of Hematology Meeting |
| 15/11/2023 | Détachement de |
| 15/11/2023 13:35 | Stifel Healthcare Conference |
| 09/11/2023 21:05 | Q1 2024 Earnings Release |
| 26/09/2023 22:00 | Q4 2023 Earnings Call |
| 26/09/2023 21:05 | Q4 2023 Earnings Release |
| 23/07/2023 15:00 | Extraordinary Shareholders Meeting - M&A Vote |
| 13/07/2023 | Extraordinary Shareholders Meeting - M&A Vote |
| 11/05/2023 21:05 | Q3 2023 Earnings Release |
| 16/04/2023 | Reverse Split: 1 of 20 |
| 23/02/2023 13:00 | MEI Pharma, Inc. and Infinity Pharmaceuticals, Inc. Merger Call |
| 09/02/2023 21:05 | Q2 2023 Earnings Release |
| 05/01/2023 17:00 | Annual General Meeting |
| 09/12/2022 | American Society of Hematology Meeting - Publication Number: 78 |
| 09/12/2022 | American Society of Hematology Meeting - Publication Number: 1563 |
Past dividends on MEI Pharma, Inc.
| 15/11/2023 | 1.75 USD |
Annual results
| Fiscal Period | June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 4,92 4,54 8.36% | 28,9 39,0 -25.87% | 25,5 19,6 30.17% | 40,7 41,8 -2.61% | 48,8 48,3 1.09% | 65,3 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -46,2 -46,4 0.42% | -24,5 -49,9 50.79% | -69,7 -76,1 8.46% | -75,5 -79,2 4.68% | -36,8 -44,7 17.79% | 23,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,8 -32,2 47.7% | -46,0 9,94 -563.06% | -50,6 -67,0 24.47% | -54,5 -58,7 7.24% | -31,8 -38,0 16.3% | 26,6 |
|
Net income Million USD | Released Forecast Spread | -16,8 -35,6 52.72% | -46,0 -40,2 -14.57% | -50,6 -64,7 21.78% | -54,5 -60,9 10.63% | -31,8 -38,0 16.3% | 26,6 |
|
EPS USD | Released Forecast Spread | -4,80 -12,3 60.84% | -10,2 -3,03 -236.79% | -9,00 -11,4 21.25% | -8,80 -9,35 5.88% | -4,78 -5,70 16.07% | 3,62 |
| Announcement Date | 28/08/19 | 09/09/20 | 02/09/21 | 08/09/22 | 26/09/23 | - |
Quarterly results
| Fiscal Period | June | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9,69 3,06 217.13% | 11,4 4,17 173.5% | 8,73 4,42 97.6% | 32,7 3,34 879.15% | 5,89 0,46 1174.85% | 1,46 0,93 56.5% | 65,3 0,00 - | 0,00 0,07 - | 0,00 0,03 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -21,6 -26,0 17.07% | -16,2 -27,2 40.38% | -18,2 -24,1 24.34% | 8,93 -26,1 134.14% | -16,4 -20,5 19.93% | -11,1 -19,0 41.8% | 55,3 -12,9 529.57% | -11,9 -10,3 -16.02% | -9,83 -11,5 14.48% | -10,9 | -14,8 | -18,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,73 -22,6 61.43% | -16,1 -26,0 38.17% | -16,6 -21,7 23.22% | 10,3 -28,6 135.8% | -15,4 -19,0 18.57% | -10,0 -16,2 38.22% | 56,4 -12,0 569.78% | -11,1 -9,47 -16.88% | -9,13 -10,7 15.04% | -9,97 | -14,2 | -18,3 |
|
Net income Million USD | Released Forecast Spread | -8,73 -23,0 62.01% | -16,1 -26,1 38.45% | -16,6 -21,7 23.22% | 10,3 -26,4 138.88% | -15,4 -19,0 18.57% | -10,0 -16,2 38.22% | 56,4 -12,0 569.78% | -11,1 -9,47 -16.88% | -9,13 -9,94 8.2% | -9,41 | -11,3 | -14,6 |
|
EPS USD | Released Forecast Spread | -1,40 -3,65 61.64% | -2,40 -3,85 37.66% | -2,40 -3,25 26.15% | 1,60 -4,20 138.1% | -2,32 -2,87 19.07% | -1,51 -2,42 37.6% | 8,46 -1,80 571.31% | -1,66 -1,41 -17.45% | -1,37 -1,49 7.85% | -1,41 | -1,70 | -2,20 |
| Announcement Date | 23/05/22 | 08/09/22 | 14/11/22 | 09/02/23 | 11/05/23 | 26/09/23 | 09/11/23 | 13/02/24 | 09/05/24 | - | - | - |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 06:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for MEI Pharma, Inc.
| 29/05/2024 21:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 14/05/2024 21:05 | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MEIP Stock
- MMI0 Stock
- Calendar MEI Pharma, Inc.
